Abstract

Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings

Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy

Issue: Mar/Apr 2013 - Volume 17, Number 2

Page(s): 168-174

Download in electronic PDF format for $75
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 1
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 2
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 3
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 4
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 5
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 6
  • Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Page 7

Abstract

The objective of this study was to establish benchmark rates for microbial and bacterial endotoxin contamination rates for radiopharmaceutical preparations compounded in commercial nuclear pharmacies. Radiopharmaceutical samples were obtained between November 2006 and June 2010 from seven commercial nuclear pharmacies. Preparations were compounded per the compounding protocols of each radiopharmacy, and each kit was used for unit-dose dispensing of patient-specific doses. Samples for testing were withdrawn after unit doses were dispensed. Sterility testing was performed on each radiopharmaceutical sample and incubated at appropriate temperatures for 14 days. A sample of the radiopharmaceutical was also used to complete limulus amebocyte lysate-based bacterial endotoxin testing. Over the course of the study, 1516 radiopharmaceutical samples from 16 different radiopharmaceutical preparations, including eluates from radionuclide generators, were tested for sterility and bacterial endotoxicity. For the sterility testing, 13 of the 1516 samples (0.86%) showed evidence of growth in the testing media, indicating the presence of microbes in the tested sample. For bacterial endotoxin testing, 4 of 1492 samples (0.27%) showed formation of gel clots, indicating the presence of bacterial endotoxins in the sample. The microbial and bacterial endotoxin contamination rates of aseptically compounded radiopharmaceuticals compounded in a commercial nuclear pharmacy environment are extremely low. The results of this study show the high level of safety and quality that is provided when obtaining radiopharmaceutical doses that are compounded and dispensed from a commercial nuclear pharmacy.

Related Keywords

  • microbial contamination
  • bacterial endotoxins
  • radiopharmaceuticals
  • nuclear pharmacy
  • nuclear medicine
  • compounded sterile preparations
  • drug safety
  • United States Pharmacopeia Chapter <797>
  • USP

Related Categories

  • NUCLEAR
  • PARENTERALS
  • PEER-REVIEWED
  • STERILE PREPARATIONS
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2013
Pg. 168-174
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Jul/Aug 2010
Pg. 317-320
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters
Author(s): Dawson Michael E
Jan/Feb 2006
Pg. 36-39
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Author(s): Dawson Michael F
Jul/Aug 2001
Pg. 259-263
Bacterial Endotoxins and Pyrogens
Author(s): Jones Marty
May/Jun 2012
Pg. 253-256
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy
Author(s): Galbraith Wendy, Shadid Jill
Nov/Dec 1998
Pg. 424-425
Introduction to Nuclear Pharmacy
Author(s): Shaw Stanley M
Jan/Feb 2011
Pg. 49-54
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Author(s): Cooper James F
Nov/Dec 2023
Pg. 483-486
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 213-221
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas
Sep/Oct 1998
Pg. 379
Testing for Bacterial Endotoxins
Author(s): Jelinek Todd
Nov/Dec 1998
Pg. 426
Physical Requirements for a Nuclear Pharmacy
Author(s): Mills Stanley L
Nov/Dec 1998
Pg. 428
Typical Day in a Nuclear Pharmacy
Author(s): Ponto James A
Nov/Dec 1998
Pg. 429-431
Prescription Preparation in a Nuclear Pharmacy: Three Case Studies
Author(s): Basmadjian Nareg
May/Jun 2015
Pg. 232-238
Basics of Sterile Compounding: Contamination Control
Author(s): Akers Michael J
Nov/Dec 2022
Pg. 497-504
Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Author(s): Summers Amy
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
May/Jun 2013
Pg. 238-246
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Jul/Aug 2020
Pg. 322-326
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Author(s): Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2014
Pg. 305-310
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
May/Jun 2008
Pg. 252-257
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Author(s): Allen Loyd V Jr, Okeke Claudia C